The genetic basis of moyamoya disease

R Mertens, M Graupera, H Gerhardt, A Bersano… - Translational stroke …, 2022 - Springer
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
spontaneous bilateral occlusion of the intracranial internal cerebral arteries (ICA) and their …

Adult Moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association/American Stroke …

NR Gonzalez, S Amin-Hanjani, OY Bang, C Coffey… - Stroke, 2023 - Am Heart Assoc
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and
mortality. A writing group of experts was selected to conduct a literature search, summarize …

Prenatal and infant exposure to acid-suppressive medications and risk of allergic diseases in children

Y Noh, HE Jeong, A Choi, EY Choi, B Pasternak… - JAMA …, 2023 - jamanetwork.com
Importance Existing observational data have indicated positive associations of acid-
suppressive medication (ASM) use in prenatal and early life with allergic diseases in …

Clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease: Longitudinal and Cross-Sectional Study

XP Wang, ZX Zou, XY Bao, QN Wang, B Ren, D Yu… - Heliyon, 2024 - cell.com
Objective This study aimed to explore the long-term outcome of unilateral moyamoya
disease and predict the clinical and genetic factors associated with contralateral progression …

[HTML][HTML] Clinical features and treatment outcomes in patients in their twenties with ischemic moyamoya disease

Y Ono, Y Akamatsu, S Araya, R Yamazaki… - Cerebrovascular …, 2024 - karger.com
Introduction: Revascularization surgery is recommended for all pediatric patients with
moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are …

Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type

YC Lim, E Lee, J Song - JAMA Network Open, 2024 - jamanetwork.com
Importance Moyamoya disease (MMD) is a rare chronic cerebrovascular disease, and the
outcomes of bypass management in adult patients remain controversial. Objective To …

Recurrent cerebral infarction due to moyamoya disease complicated with systemic lupus erythematosus: a case report and literature review

Q Wang, Q Yao, S Yuan, Y Shen, Y Feng, L Liu… - The …, 2024 - journals.lww.com
Conclusions: This was a 32-year-old young patient diagnosed with moyamoya disease
carrying RNF213 gene mutation and accompanied by lupus with cerebral ischemic event as …

Clinical Course, Therapy, and Long-Term Outcomes of Children With Moyamoya Disease and Posterior Cerebral Artery Involvement

H Wang, F Hao, J Feng, Q Zhang, Z Zhang, B Li… - Neurology, 2024 - neurology.org
Background and Objectives Posterior cerebral artery involvement (PCAi) has been identified
as an important factor related to poor prognosis in moyamoya disease (MMD). This study …

17q25. 3 copy number changes: association with neurodevelopmental disorders and cardiac malformation

NS Sahajpal, DHF Jeffrey, BR DuPont, B Hilton - Molecular Cytogenetics, 2023 - Springer
Copy number variants (CNVs) have been identified as common genomic variants that play a
significant role in inter-individual variability. Conversely, rare recurrent CNVs have been …

Risk Factors for Massive Cerebral Infarction in Pediatric Patients With Moyamoya Disease

F Hao, G Gao, Q Guo, S Liu, M Wang, Z Chang… - Pediatric Neurology, 2024 - Elsevier
Background To explore the risk factors for preoperative massive cerebral infarction (MCI) in
pediatric patients with moyamoya disease (MMD). Methods Pediatric patients with MMD …